Literature DB >> 26191320

Enlarging cystic lymphangioma of the mediastinum in an adult: is this a neoplastic lesion related to the recently discovered PIK3CA mutation?

Shogo Tajima1, Yusuke Takanashi2, Kenji Koda3.   

Abstract

Cystic lymphangioma, a lymphatic system malformation, is usually observed in infants and children and is rarely found in adults. It most commonly occurs in the cervicofacial region, followed by the axilla. Mediastinal cystic lymphangioma is rare, accounting for 1.8% of all mediastinal cysts. Herein, we present an exceedingly rare adult case of mediastinal cystic lymphangioma that had increased in size over a 5-year period. Although fluid collection might be an alternative explanation for this increase in size, this lymphangioma might harbor a neoplastic nature related to the recently discovered PIK3CA mutation.

Entities:  

Keywords:  Cystic lymphangioma; PIK3CA; adult; mediastinum

Mesh:

Substances:

Year:  2015        PMID: 26191320      PMCID: PMC4503191     

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


  12 in total

1.  Molecular characterization of lymphatic endothelial cells.

Authors:  Simona Podgrabinska; Pascal Braun; Paula Velasco; Bryan Kloos; Michael S Pepper; Mihaela Skobe
Journal:  Proc Natl Acad Sci U S A       Date:  2002-11-22       Impact factor: 11.205

2.  ISSVA classification.

Authors:  Roshni Dasgupta; Steven J Fishman
Journal:  Semin Pediatr Surg       Date:  2014-06-19       Impact factor: 2.754

Review 3.  Vascular anomalies: A pictorial review of nomenclature, diagnosis and treatment.

Authors:  John L Nosher; Philip G Murillo; Mark Liszewski; Vyacheslav Gendel; Christopher E Gribbin
Journal:  World J Radiol       Date:  2014-09-28

4.  Immunoelectron microscopic characterization of human dermal lymphatic microvascular endothelial cells. Differential expression of CD31, CD34, and type IV collagen with lymphatic endothelial cells vs blood capillary endothelial cells in normal human skin, lymphangioma, and hemangioma in situ.

Authors:  B Sauter; D Foedinger; B Sterniczky; K Wolff; K Rappersberger
Journal:  J Histochem Cytochem       Date:  1998-02       Impact factor: 2.479

5.  Monoclonal antibody D2-40, a new marker of lymphatic endothelium, reacts with Kaposi's sarcoma and a subset of angiosarcomas.

Authors:  Harriette J Kahn; Denis Bailey; Alexander Marks
Journal:  Mod Pathol       Date:  2002-04       Impact factor: 7.842

6.  Mesenteric cysts and intra-abdominal cystic lymphangiomas.

Authors:  H Takiff; R Calabria; L Yin; B E Stabile
Journal:  Arch Surg       Date:  1985-11

7.  Intrathoracic lymphangioma.

Authors:  L R Brown; H M Reiman; E C Rosenow; P M Gloviczki; M B Divertie
Journal:  Mayo Clin Proc       Date:  1986-11       Impact factor: 7.616

8.  PI3K signalling: the path to discovery and understanding.

Authors:  Bart Vanhaesebroeck; Len Stephens; Phillip Hawkins
Journal:  Nat Rev Mol Cell Biol       Date:  2012-02-23       Impact factor: 94.444

9.  Mediastinal cystic lymphangioma in a patient with situs inversus totalis.

Authors:  Teruya Komatsu; Yutaka Takahashi
Journal:  Case Rep Surg       Date:  2014-11-06

10.  Lymphatic and other vascular malformative/overgrowth disorders are caused by somatic mutations in PIK3CA.

Authors:  Valerie L Luks; Nolan Kamitaki; Matthew P Vivero; Wibke Uller; Rashed Rab; Judith V M G Bovée; Kristy L Rialon; Carlos J Guevara; Ahmad I Alomari; Arin K Greene; Steven J Fishman; Harry P W Kozakewich; Reid A Maclellan; John B Mulliken; Reza Rahbar; Samantha A Spencer; Cameron C Trenor; Joseph Upton; David Zurakowski; Jonathan A Perkins; Andrew Kirsh; James T Bennett; William B Dobyns; Kyle C Kurek; Matthew L Warman; Steven A McCarroll; Rudy Murillo
Journal:  J Pediatr       Date:  2015-02-11       Impact factor: 4.406

View more
  1 in total

1.  In vitro efficacy of ARQ 092, an allosteric AKT inhibitor, on primary fibroblast cells derived from patients with PIK3CA-related overgrowth spectrum (PROS).

Authors:  C Ranieri; S Di Tommaso; D C Loconte; V Grossi; P Sanese; R Bagnulo; F C Susca; G Forte; A Peserico; A De Luisi; A Bartuli; A Selicorni; D Melis; M Lerone; A D Praticò; G Abbadessa; Y Yu; B Schwartz; Martino Ruggieri; Cristiano Simone; Nicoletta Resta
Journal:  Neurogenetics       Date:  2018-03-16       Impact factor: 2.660

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.